Vasculature-On-A-Chip for In Vitro Disease Models

Area of Science:

• Biomedical Engineering
• Developmental Biology
• Physiology

Background:

• Vascularization, the formation of new blood vessels, is crucial for physiological processes.
• The vasculature is implicated in numerous human diseases, necessitating further research.
• Advances in understanding vascularization enable in vitro recapitulation.

Purpose of the Study:

• To review microfluidic assay fabrication methods for vascularization.
• To discuss factors that induce vascularization in vitro.
• To explore applications of engineered vasculature in disease modeling and drug discovery.

Main Methods:

• Review of microfluidic system fabrication techniques.
• Analysis of various factors influencing in vitro vascularization.
• Compilation of current applications in disease modeling and drug screening.

Main Results:

• Microfluidic systems facilitate detailed study of vascularization cues.
• In vitro vascularization technologies show promise for disease modeling.
• Engineered vasculature is applicable to organ-on-chips and drug screening.

Conclusions:

• Microfluidic platforms offer powerful tools for vascularization research.
• Engineered vasculature advances the study of vascular diseases.
• In vitro models are valuable for drug development and screening.